C71T
CANCELLED SECTION 71
24/07/2026
Voltar para busca
Dado oficial do USPTO
GELMETIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
GELMETIX
ST13
US500000079261320Classe
5, 10, 42, 44
Pedido
79261320
Registro
5952468
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
24/07/2026
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
12/03/2019
Data de registro
07/01/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/07/2026
Última transação
24/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
GB
Examinador
MCCAULEY, BRENDAN D
Unidade examinadora
M50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Gelmetix Limited
Representantes
Elissa A. Tisdahl Weisberg I.P. Law, P.A.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationspolymer gels for injection in to the body to relieve pain and treat osteoarthritis; Gel based material for medicalsurgical and orthopaedic purposesinjectable gels for use in the treatment of chronic pain and repair of joints; Intervertebral disc and joint fillersgels for use in the treatment of chronic pain and repair of joints; Pharmaceutical preparations for the treatment of joint and intervertebral disc diseases; Pharmaceutical implantsinjectable gel implants for use in the treatment of chronic pain and repair of joints
Classe 10
Surgical apparatus and instruments for medical use; Medical apparatus and devicesmedical apparatus and devices for use in orthopaedic surgery and surgical implants comprising of artificial material; Intervertebral disc and joint implants made of artificial materials and intervertebral disc and joint implants made of artificial materials with natural materials; Intervertebral disc and joint fillers made of synthetic materials for use in orthopaedic surgical procedures; Medical implants made of artificial materials; Orthopaedic implants comprised of artificial materials; Surgical implants comprised of primarily artificial materials with natural living materials; Devices for the administration and/or implantation of the medical and surgical implantscanulae needlecatheter syringesaspirator and connector adapters and medical mechanical syringe pumps for medical syringes
Classe 42
Medical research; Medical research services; Consultancy in the field of pharmaceuticalmedical or surgical research; Pharmaceutical research and development; Pharmaceutical research and development services; Scientific investigations for medical purposes; medical product research and development consultancy in the fields of medical devices and clinical use of medical devices; medical product research and development technical support services in the fields of medical devices and clinical use of medical devices; providing medical research information and product research information in the field of medical devices
Classe 44
Medical services; Medical advisory services and technical support medical advisory services for surgical and/or medical procedures; Providing medical information relating to orthopaedicsorthopaedic implantsorthopaedic surgerypain management proceduresthe diagnosis and treatment of spinal and orthopaedic conditions resulting from degenerative and ageing diseases
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/01/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
30/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/12/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/12/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/06/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
14/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/06/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/05/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/04/2020
FIMP
FINAL DISPOSITION PROCESSED
18/04/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/10/2019
PUBO
PUBLISHED FOR OPPOSITION
22/10/2019
GPNX
NOTIFICATION PROCESSED BY IB
19/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/10/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/10/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/09/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
13/09/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/09/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
13/09/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2019
ALIE
ASSIGNED TO LIE
03/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/08/2019
RFNT
REFUSAL PROCESSED BY IB
09/08/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/07/2019
RFRR
REFUSAL PROCESSED BY MPU
23/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
29/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/06/2019
CNRT
NON-FINAL ACTION WRITTEN
26/06/2019
DOCK
ASSIGNED TO EXAMINER
25/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GELMETIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.